Acorda Therapeutics reported $41.12M in Current Liabilities for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 117.68M 1.92M
Acorda Therapeutics ACOR:US $ 41.12M 4.88M
Agios Pharmaceuticals AGIO:US $ 48.4M 2.6M
ALKERMES ALKS:US $ 438.52M 23.84M
Amgen AMGN:US $ 12618M 268M
Anika Therapeutics ANIK:US $ 29.43M 2.44M
Aptinyx Inc APTX:US $ 5.68M 945K
Arrowhead Research ARWR:US $ 128.21M 10.64M
Biogen BIIB:US $ 5018M 1071.4M
Biomarin Pharmaceutical BMRN:US $ 464.73M 25.69M
Cara Therapeutics CARA:US $ 21.17M 2.87M
Clovis Oncology CLVS:US $ 121.27M 0.56M
Cytokinetics CYTK:US $ 66.84M 0M
Enanta Pharmaceuticals ENTA:US $ 23.04M 7.7M
Gilead Sciences GILD:US $ 9220M 662M
GlaxoSmithKline GSK:LN 3783500M 1355700M
Halozyme Therapeutics HALO:US $ 199.51M 87.82M
Heron Therapeutics HRTX:US $ 109.5M 16.5M
Insmed INSM:US $ 113.82M 11.43M
Ligand Pharmaceuticals LGND:US $ 167.85M 125.28M
Mannkind MNKD:US $ 59.56M 6.07M
Merck MRK:GR € 9718M 489M
Moderna Inc MRNA:US 6.81B 2.43B
Neurocrine Biosciences NBIX:US $ 285.7M 32.2M
Novartis NOVN:VX SF 27646M 2161M
Teva Pharmaceutical TEVA:IT 11B 617M
Ultragenyx Pharmaceutical RARE:US $ 220.64M 53.4M
Vertex Pharmaceuticals VRTX:US $ 2556.2M 376M